CoChat

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.

Open access
May, W A, Lessnick, S L, Braun, B S, Klemsz, M, Lewis, B C, Lunsford, L B, Hromas, R, Denny, C T · 1993 · Molecular and Cellular Biology

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

EWS/FLI-1 is a chimeric protein formed by a tumor-specific 11;22 translocation found in both Ewing's sarcoma and primitive neuroectodermal tumor of childhood. EWS/FLI-1 has been shown to be a potent transforming gene, suggesting that it plays an important role in the genesis of these human tumors. We now demonstrate that EWS/FLI-1 has the characteristics of an aberrant transcription factor. Subcellular fractionation experiments localized the EWS/FLI-1 protein to the nucleus of primitive neuroectodermal tumor cells. EWS/FLI-1 specifically bound in vitro an ets-2 consensus sequence similarly to normal FLI-1. When coupled to a GAL4 DNA-binding domain, the amino-terminal EWS/FLI-1 region was a much more potent transcriptional activator than the corresponding amino-terminal domain of FLI-1. Finally, EWS/FLI-1 efficiently transformed NIH 3T3 cells, but FLI-1 did not. These data suggest that EWS/FLI-1, functioning as a transcription factor, leads to a phenotype dramatically different from that of cells expressing FLI-1. EWS/FLI-1 could disrupt normal growth and differentiation either by more efficiently activating FLI-1 target genes or by inappropriately modulating genes normally not responsive to FLI-1.

Overview

Integrity signals

Registry

Crossref · 10.1128/mcb.13.12.7393

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 562

Metadata

Authors
May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T.
Affiliations
University of California, Los Angeles (US)
Venue
Molecular and Cellular Biology
Published
1993-12
Volume
13
Issue
12
Pages
7393-7398
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W1789215739
Cited by
497
References
33
Citations by year
2026: 2 · 2025: 4 · 2024: 8 · 2023: 13 · 2022: 8 · 2021: 12 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 8 · 2016: 16 · 2015: 15 · 2014: 22 · 2013: 25 · 2012: 20
FWCI
11.85
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Cancer Institute
  • National Institute of General Medical Sciences (T32GM008042)
  • National Institute of Allergy and Infectious Diseases (T32AI007126)
Topics
  • Health Sciences › Medicine › Oncology › Sarcoma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
FLI1, Ewing sarcoma, primitive neuroectodermal tumor, 22 translocation, transcriptional activator, GAL4 DNA-binding domain, nuclear localization
MeSH terms
Animals, Base Sequence, Binding Sites, Cell Line, Cell Nucleus, Cell Transformation, Neoplastic, Chromosomes, Human, Pair 11, Chromosomes, Human, Pair 22, Cloning, Molecular, DNA-Binding Proteins, DNA, Neoplasm, HeLa Cells, Humans, Molecular Sequence Data, Oncogenes, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Sarcoma, Ewing, Translocation, Genetic, Trans-Activators, 3T3 Cells, Mice, Proto-Oncogene Protein c-fli-1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.